Hyun‐Gyung Goh
Hyun‐Gyung Goh publishes mostly in Hematology, Genetics and Rheumatology, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Eosinophilic Disorders and Syndromes.
- World rank
- #4,946,907 of 7,710,434 ranked researchers
- Rank in South Korea
- #87,268 of 162,609
- Works
- 23
- Citations
- 747
- Citations per work
- 32.5
What does Hyun‐Gyung Goh research?
Hyun‐Gyung Goh's work is mostly in Medicine (84%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1984.1%
- Medicine1984.1%
- Everything else210.1%
- Life Sciences15.8%
- 1Hematology35% of their works
- 2Genetics29% of their works
- 3Rheumatology12% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Molecular Biology3% of their works
- 6Genetics3% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Eosinophilic Disorders and Syndromes
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Genetic Mapping and Diversity in Plants and Animals
Which keywords describe Hyun‐Gyung Goh's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification and Fusion Genes.
- Genome-wide Association Studies
- JAK2 Mutation
- Acute Myeloid Leukemia
- AML
- Lymphoma
- Fusion Genes
- Genomic Aberrations
- Imatinib
- Prognostic Factors
- Rituximab
- BCR-ABL
- Chronic Lymphocytic Leukemia
- Classification
- Hypereosinophilic Syndrome
- Molecular Profiling
- Acute Lymphoblastic Leukemia
- Childhood Cancer
- Myelofibrosis
- Quantitative Trait Loci
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Rituximab242 topics
- Prognostic Factors223 topics
- BCR-ABL211 topic
- Imatinib211 topic
- Chronic Lymphocytic Leukemia181 topic
- Genomic Aberrations181 topic
- Classification142 topics
- Fusion Genes81 topic
- Hypereosinophilic Syndrome81 topic
- Lymphoma61 topic
- Molecular Profiling61 topic
- AML21 topic
- Acute Lymphoblastic Leukemia21 topic
- Acute Myeloid Leukemia21 topic
- Childhood Cancer21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
- Genome-wide Association Studies11 topic
- Quantitative Trait Loci11 topic
Where does Hyun‐Gyung Goh work?
Hyun‐Gyung Goh's main affiliation in the publication record is Catholic University of Korea, South Korea.
How many publications and citations does Hyun‐Gyung Goh have?
OpenAlex counts 23 works and 747 citations for Hyun‐Gyung Goh, an h-index of 13, ranking #4,946,907 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hyun‐Gyung Goh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.